These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8030316)

  • 1. [The immunological aspects of the antibacterial therapy of peptic ulcer patients].
    Bychkova NG; Petrov AV; Perederiĭ VG; Iurchenko ES
    Lik Sprava; 1993; (10-12):79-81. PubMed ID: 8030316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
    Karita M; Tsuda M; Okita K; Sugiyama T; Nakazawa T
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S31-4. PubMed ID: 8574732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial effectiveness of furazolidone against metronidazole-resistant strains of Helicobacter pylori.
    Safaralizadeh R; Siavoshi F; Malekzadeh R; Akbari MR; Derakhshan MH; Sohrabi MR; Massarrat S
    East Mediterr Health J; 2006; 12(3-4):286-93. PubMed ID: 17037696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The drug prophylaxis of peptic ulcer exacerbations].
    Grigor'ev PIa; Iakovenko EP; Agafonova NA; Prianishnikova AS; Soluianova IP; Iakovenko AV; Vasil'ev IV; Agrba VZ; Stepanov AV; Kolodkin AM
    Ter Arkh; 1995; 67(2):26-9. PubMed ID: 7725253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Furazolidone-based, metronidazole-based, or a combination regimen for eradication of Helicobacter pylori in peptic ulcer disease.
    Khatibian M; Ajvadi Y; Nasseri-Moghaddam S; Ebrahimi-Dariani N; Vahedi H; Zendehdel N; Sotoudehmanesh R; Agah S; Mikaeli J; Pourshams A; Ali-Asgari A; Malekzadeh R; Massarrat S
    Arch Iran Med; 2007 Apr; 10(2):161-7. PubMed ID: 17367217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease.
    Ghadir MR; Shafaghi A; Iranikhah A; Pakdin A; Joukar F; Mansour-Ghanaei F
    Turk J Gastroenterol; 2011 Feb; 22(1):1-5. PubMed ID: 21480103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical evaluation of the treatment of peptic ulcer diseases associated with Helicobacter pylori infection.
    Gabryelewicz A
    J Physiol Pharmacol; 1996 Mar; 47(1):51-8. PubMed ID: 8777307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
    Leodolter A; Peitz U; Malfertheiner P
    Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy].
    Iwasaki A
    Nihon Rinsho; 1999 Jan; 57(1):127-33. PubMed ID: 10036949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori in peptic ulcer disease.
    Del Med J; 1994 Oct; 66(10):557-8. PubMed ID: 7958122
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of duodenal ulcer concomitant with successful Helicobacter pylori eradication.
    Pohle T; Hilker E; Domschke W
    Z Gastroenterol; 1997 Jul; 35(7):563-5. PubMed ID: 9273989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication therapy in peptic ulcer disease.
    MacConnachie AM
    Intensive Crit Care Nurs; 1997 Apr; 13(2):121-2. PubMed ID: 9180502
    [No Abstract]   [Full Text] [Related]  

  • 16. Helicobacter pylori eradication in peptic dyspepsia.
    Lule GN
    East Afr Med J; 2005 Dec; 82(12):601-2. PubMed ID: 16619702
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease.
    Walsh JH; Peterson WL
    N Engl J Med; 1995 Oct; 333(15):984-91. PubMed ID: 7666920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The principles of administering drug and non-drug treatment methods in peptic ulcer].
    Perederiĭ VG; Bychkova NG; Petrov AV; Seliuk MN; Dogotar' VB; Iurchenko ES; Tkach SM; Shvets GL; Vysotiuk LA; Marusanich BN
    Lik Sprava; 1993; (5-6):58-61. PubMed ID: 8209501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment characteristics of patients with peptic ulcer infected with Helicobacter pylori].
    Kharchenko NV
    Lik Sprava; 1999 Mar; (2):70-4. PubMed ID: 10424047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.